autologous car-engineered regulatory t-cells sbt777101
autologous car-engineered regulatory t-cells sbt777101: 2 clinical trials tracked.
autologous car-engineered regulatory t-cells sbt777101 evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
What is verified about autologous car-engineered regulatory t-cells sbt777101, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (2)
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Single Ascending Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
Primary endpoint: Incidence, nature, and severity of adverse events [Safety and Tolerability]
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Single Ascending Doses of SBT777101 in Subjects With Rheumatoid Arthritis
Primary endpoint: Incidence, nature, and severity of adverse events [Safety and Tolerability]